Cancer immunotherapy has evolved dramatically with improved understanding of immune
microenvironment and immunosurveillance. The immunogenicity of breast cancer is rather …

Breast cancer (BC) is a persistent global challenge for its high frequency in women
(although it seldom occurs in men), due to the large diffusion of risk factors and gene …

In this study, we investigated the effects of calycosin on breast cancer cell progression and
their underlying mechanisms. Calycosin dose-and time-dependently inhibited proliferation …

Background Despite advancements in therapies, brain metastasis in patients with triple
negative subtype of breast cancer remains a therapeutic challenge. Activated microglia are …

Purpose Low socioeconomic status (SES) is associated with advanced stage, lower-quality
care, and higher mortality among breast cancer patients. The purpose of this study is to …

Introduction Breast cancer (BC) is the first common neoplastic malignancy and the second
leading cause of death in women worldwide. Conventional treatments for BC are often …

Background/Aims: Calycosin, a phytoestrogenic compound, has recently emerged as a
promising antitumor drug. It has been shown that calycosin suppresses growth and induces …

Objective: To evaluate the comparative therapeutic efficacy of radiofrequency ablation (RFA)
and hepatic resection (HR) for breast cancer liver metastases (BCLMs). Methods: Studies …

Simple Summary Approximately 8% of breast cancers are diagnosed with synchronous
distant metastasis at initial diagnosis, a situation known as de novo metastatic disease …

Since 2019, the world has been experiencing an outbreak of a novel beta-coronavirus,
severe acute respiratory syndrome coronavirus (SARS-CoV)-2. The worldwide spread of this …